$NMUS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Skye Bioscience, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Skye Bioscience, Inc.. Get notifications about new insider transactions in Skye Bioscience, Inc. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 12 2020 | NMUS | Emerald Bioscience ... | DALESANDRO MARGARET | Director | Option Exercise | A | 0.05 | 250,000 | 11,250 | 250,000 | |
Aug 11 2020 | NMUS | Emerald Bioscience ... | Emerald Health Sciences Inc. | Sell | S | 0.10 | 3,000,000 | 300,000 | 123,490,167 | 126.5 M to 123.5 M (-2.37 %) | |
Aug 11 2020 | NMUS | Emerald Bioscience ... | DHILLON PUNIT | CEO | Option Exercise | A | 0.05 | 9,000,000 | 405,000 | 9,200,000 | |
Aug 11 2020 | NMUS | Emerald Bioscience ... | DHILLON PUNIT | CEO | Buy | P | 100,000.00 | 1,000,000 | 100,000,000,000 | 1,000,000 | 0 to 1000 K |
Aug 11 2020 | NMUS | Emerald Bioscience ... | HEPPELL JAMES L | Option Exercise | A | 0.05 | 1,000,000 | 45,000 | 1,200,000 | ||
Aug 11 2020 | NMUS | Emerald Bioscience ... | HEPPELL JAMES L | Buy | P | 50,000.00 | 500,000 | 25,000,000,000 | 500,000 | 0 to 500 K | |
Aug 11 2020 | NMUS | Emerald Bioscience ... | KIM DENNIS D | Chief Medical Offic ... | Option Exercise | A | 0.05 | 4,000,000 | 180,000 | 4,736,541 | |
Aug 11 2020 | NMUS | Emerald Bioscience ... | Traistaru Elena | CFO and Secretary | Option Exercise | A | 0.05 | 1,000,000 | 45,000 | 1,000,000 | |
Jan 28 2020 | NMUS | Emerald Bioscience ... | Emerald Health Sciences Inc. | Option Exercise | J | 0.40 | 4,080,000 | 1,632,000 | 5,036,250 | ||
Jan 28 2020 | NMUS | Emerald Bioscience ... | Emerald Health Sciences Inc. | Option Exercise | J | 0.10 | 40,800,000 | 4,080,000 | 0 | ||
Jan 28 2020 | NMUS | Emerald Bioscience ... | Emerald Health Sciences Inc. | Buy | J | 4,080,000.00 | 40,800,000 | 166,464,000,000,000 | 126,490,167 | 85.7 M to 126.5 M (+47.61 %) | |
Aug 23 2019 | NMUS | Emerald Bioscience ... | KIM DENNIS D | Chief Medical Offic ... | Option Exercise | A | 0.30 | 736,541 | 220,962 | 736,541 | |
Aug 23 2019 | NMUS | Emerald Bioscience ... | KIM DENNIS D | Chief Medical Offic ... | Option Exercise | A | 0.30 | 736,541 | 220,962 | 736,541 | |
Apr 01 2019 | NMUS | Emerald Bioscience ... | Emerald Health Sciences Inc. | Option Exercise | J | 0.50 | 2,500,000 | 1,250,000 | 7,500,000 | ||
Apr 01 2019 | NMUS | Emerald Bioscience ... | Emerald Health Sciences Inc. | Option Exercise | J | 0.40 | 2,000,000 | 800,000 | 6,000,000 | ||
Feb 01 2019 | NMUS | Nemus Bioscience, ... | Emerald Health Sciences Inc. | 10% Owner | Option Exercise | J | 0.50 | 2,500,000 | 1,250,000 | 2,500,000 | |
Dec 28 2018 | NMUS | Nemus Bioscience, ... | Emerald Health Sciences Inc. | 10% Owner | Buy | J | 0.00 | 37,667 | 0 | 73,153,917 | 73.1 M to 73.2 M (+0.05 %) |
Nov 01 2018 | NMUS | Nemus Bioscience, ... | Emerald Health Sciences Inc. | 10% Owner | Option Exercise | J | 0.50 | 2,500,000 | 1,250,000 | 2,500,000 | |
Oct 12 2018 | NMUS | Nemus Bioscience, ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.31 | 1,000,000 | 305,000 | 1,000,000 | |
Oct 12 2018 | NMUS | Nemus Bioscience, ... | HEPPELL JAMES L | Director | Option Exercise | A | 0.31 | 200,000 | 61,000 | 200,000 | |
Oct 12 2018 | NMUS | Nemus Bioscience, ... | DHILLON PUNIT | Director | Option Exercise | A | 0.31 | 200,000 | 61,000 | 200,000 | |
Jul 23 2018 | NMUS | Nemus Bioscience, ... | Cesario Douglas A | CFO and Secretary | Option Exercise | A | 0.25 | 1,195,073 | 292,793 | 1,195,073 | |
Jul 23 2018 | NMUS | Nemus Bioscience, ... | Cesario Douglas A | CFO and Secretary | Grant | A | 0.00 | 643,501 | 0 | 643,501 | 0 to 643.5 K |
Apr 03 2018 | NMUS | Nemus Bioscience, ... | Emerald Health Sciences Inc. | 10% Owner | Option Exercise | C | 0.10 | 2,000 | 200 | 0 | |
Apr 03 2018 | NMUS | Nemus Bioscience, ... | Emerald Health Sciences Inc. | 10% Owner | Option Exercise | C | 0.10 | 1,234 | 123 | 0 | |
Apr 03 2018 | NMUS | Nemus Bioscience, ... | Emerald Health Sciences Inc. | 10% Owner | Buy | C | 0.10 | 20,000,000 | 2,000,000 | 73,116,250 | 53.1 M to 73.1 M (+37.65 %) |
Apr 03 2018 | NMUS | Nemus Bioscience, ... | Emerald Health Sciences Inc. | 10% Owner | Buy | C | 0.10 | 12,335,000 | 1,233,500 | 53,116,250 | 40.8 M to 53.1 M (+30.25 %) |
Mar 02 2018 | NMUS | Nemus Bioscience, ... | Emerald Health Sciences Inc. | 10% Owner | Option Exercise | X | 0.00 | 1,781,250 | 1,781 | 0 | |
Mar 02 2018 | NMUS | Nemus Bioscience, ... | Emerald Health Sciences Inc. | 10% Owner | Buy | X | 0.00 | 1,781,250 | 1,781 | 40,781,250 | 39 M to 40.8 M (+4.57 %) |
Feb 21 2018 | NMUS | Nemus Bioscience, ... | Emerald Health Sciences Inc. | 10% Owner | Option Exercise | P | 0.10 | 20,400,000 | 2,040,000 | 20,400,000 | |
Feb 21 2018 | NMUS | Nemus Bioscience, ... | Emerald Health Sciences Inc. | 10% Owner | Buy | P | 0.00 | 15,000,000 | 0 | 39,000,000 | 24 M to 39 M (+62.50 %) |
Jan 22 2018 | NMUS | Nemus Bioscience, ... | Murphy Brian Stuart | CEO, Chief Medical ... | Grant | A | 0.00 | 900,000 | 0 | 1,275,000 | 375 K to 1.3 M (+240.00 %) |
Jan 22 2018 | NMUS | Nemus Bioscience, ... | LYKOS COSMAS N | Chairman | Grant | A | 0.00 | 900,000 | 0 | 4,599,400 | 3.7 M to 4.6 M (+24.33 %) |
Jan 22 2018 | NMUS | Nemus Bioscience, ... | Berecz Elizabeth | Chief Financial Off ... | Grant | A | 0.00 | 700,000 | 0 | 1,050,000 | 350 K to 1.1 M (+200.00 %) |
Mar 28 2017 | NMUS | Nemus Bioscience, ... | Lapham Reg Alexander | 10% Owner | Sell | X | 1.00 | 119,700 | 119,700 | 3,787,500 | 3.9 M to 3.8 M (-3.06 %) |
Oct 22 2015 | NMUS | Nemus Bioscience, ... | INGRAM DOUGLAS S | Vice Chairman | Grant | A | 0.00 | 60,000 | 0 | 372,500 | 312.5 K to 372.5 K (+19.20 %) |
Oct 22 2015 | NMUS | Nemus Bioscience, ... | McLaughlin Gerald W. | Director | Grant | A | 0.00 | 30,000 | 0 | 61,250 | 31.3 K to 61.3 K (+96.00 %) |
Oct 22 2015 | NMUS | Nemus Bioscience, ... | GEORGE THOMAS | Director | Grant | A | 0.00 | 60,000 | 0 | 60,000 | 0 to 60 K |
Oct 22 2015 | NMUS | Nemus Bioscience, ... | LYKOS COSMAS N | Chairman | Grant | A | 0.00 | 325,000 | 0 | 3,699,400 | 3.4 M to 3.7 M (+9.63 %) |
Oct 22 2015 | NMUS | Nemus Bioscience, ... | Berecz Elizabeth | Chief Financial Off ... | Grant | A | 0.00 | 350,000 | 0 | 350,000 | 0 to 350 K |
Oct 22 2015 | NMUS | Nemus Bioscience, ... | Murphy Brian Stuart | CEO, Chief Medical ... | Grant | A | 0.00 | 375,000 | 0 | 375,000 | 0 to 375 K |
Aug 24 2015 | NMUS | Nemus Bioscience, ... | INGRAM DOUGLAS S | Vice Chairman | Option Exercise | C | 0.00 | 100,000 | 0 | 0 | |
Aug 24 2015 | NMUS | Nemus Bioscience, ... | INGRAM DOUGLAS S | Vice Chairman | Buy | C | 0.00 | 312,500 | 0 | 312,500 | 0 to 312.5 K |
Aug 24 2015 | NMUS | Nemus Bioscience, ... | McLaughlin Gerald W. | Director | Option Exercise | C | 0.00 | 10,000 | 0 | 0 | |
Aug 24 2015 | NMUS | Nemus Bioscience, ... | McLaughlin Gerald W. | Director | Buy | C | 0.00 | 31,250 | 0 | 31,250 | 0 to 31.3 K |
Jun 03 2015 | NMUS | Nemus Bioscience, ... | INGRAM DOUGLAS S | Vice Chairman | Option Exercise | A | 3.00 | 40,000 | 120,000 | 40,000 | |
Jun 02 2015 | NMUS | Nemus Bioscience, ... | McLaughlin Gerald W. | Director | Option Exercise | P | 5.00 | 2,000 | 10,000 | 2,000 | |
Jun 02 2015 | NMUS | Nemus Bioscience, ... | McLaughlin Gerald W. | Director | Option Exercise | P | 2.50 | 10,000 | 25,000 | 10,000 | |
Apr 10 2015 | NMUS | Nemus Bioscience, ... | Ladin Brian D | 10% Owner | Sell | S | 4.93 | 11,830 | 58,310 | 249,098 | 260.9 K to 249.1 K (-4.53 %) |
Apr 10 2015 | NMUS | Nemus Bioscience, ... | Ladin Brian D | 10% Owner | Sell | S | 4.79 | 15,800 | 75,682 | 260,928 | 276.7 K to 260.9 K (-5.71 %) |
Apr 10 2015 | NMUS | Nemus Bioscience, ... | Ladin Brian D | 10% Owner | Sell | S | 4.69 | 23,000 | 107,893 | 276,728 | 299.7 K to 276.7 K (-7.67 %) |
Jan 12 2015 | NMUS | Nemus Bioscience, ... | GEORGE THOMAS | Director | Option Exercise | A | 3.00 | 40,000 | 120,000 | 40,000 | |
Dec 08 2014 | NMUS | Nemus Bioscience, ... | McLaughlin Gerald W. | Director | Option Exercise | A | 0.42 | 20,000 | 8,400 | 20,000 | |
Dec 08 2014 | NMUS | Nemus Bioscience, ... | LYKOS COSMAS N | Chairman | Option Exercise | A | 0.42 | 125,000 | 52,500 | 125,000 | |
Dec 08 2014 | NMUS | Nemus Bioscience, ... | Berecz Elizabeth | Chief Financial Off ... | Option Exercise | A | 0.42 | 150,000 | 63,000 | 150,000 | |
Dec 08 2014 | NMUS | Nemus Bioscience, ... | Berecz Elizabeth | Chief Financial Off ... | Option Exercise | A | 0.42 | 100,000 | 42,000 | 100,000 | |
Dec 08 2014 | NMUS | Nemus Bioscience, ... | Murphy Brian Stuart | Chief Medical Offic ... | Option Exercise | A | 0.42 | 175,000 | 73,500 | 175,000 | |
Dec 08 2014 | NMUS | Nemus Bioscience, ... | Murphy Brian Stuart | Chief Medical Offic ... | Option Exercise | A | 0.42 | 480,000 | 201,600 | 480,000 | |
Dec 08 2014 | NMUS | Nemus Bioscience, ... | Hollister John B | Chief Executive Off ... | Option Exercise | A | 0.42 | 200,000 | 84,000 | 200,000 | |
Dec 08 2014 | NMUS | Nemus Bioscience, ... | Hollister John B | Chief Executive Off ... | Option Exercise | A | 0.42 | 480,000 | 201,600 | 480,000 | |
Nov 10 2014 | NMUS | Nemus Bioscience, ... | Mendez Yosbani | Sell | J | 0.00 | 4,251,460 | 0 | 2,440 | 4.3 M to 2.4 K (-99.94 %) | |
Nov 10 2014 | NMUS | Nemus Bioscience, ... | MENDEZ FRANCISCO JAVIER | Sell | J | 0.00 | 500,000 | 0 | 0 | 500 K to 0 (-100.00 %) |
Page: 1